tbuckley/cabot-search huggingface dataset:
51444 Potential Underutilization of Biologic Therapies and Description of Healthcare Resource Utilization (HCRU) in US Veterans With Chronic Spontaneous Urticaria (CSU)
Authors: Lillian Sun, Fatai Y. Agiri, Peter N. Danilov, Gailen Marshall, Jonathan Rodrigues, Ashley Post, Dhaval Patil, Wing Chow, Amit Garg, Julie A. Lynch, Elma D. Baron
Journal: Journal of the American Academy of Dermatology (2024)
52151 Advancing the Diagnosis of Dermatologic Conditions: Utilizing Deep Neural Networks for Accurate Differentiation between Actinic Keratosis and Squamous Cell Carcinoma
Authors: Pasha Mazboudi, Monica Guirgus, Parsa Riazi, Akshay Reddy, Victoria Farasat, Casey Curow, Maya Maalouf
Journal: Journal of the American Academy of Dermatology (2024)
52065 Results of adjuvant therapy for melanoma in real life: a retrospective cohort study
Authors: Mar Luque-Luna, Mariona Gracia-Rius, Pablo Iglesias, Mireia Santos, Francesca Crespí, Marc Combalia, Cristina Carrera, Sebastian Podlipnik, Josep Malvehy, Susana Puig
Journal: Journal of the American Academy of Dermatology (2024)
52272 Ceramide profiling of atopic dermatitis and effects of an eczema calming lotion containing petroleum jelly, fatty acids and colloidal oatmeal.
Authors: Andrew E. Mayes, Galina Yarova, William Lathrop, Lin Feng, John Bajor, Jane Scott, Melody Edmunds, Stacy S. Hawkins, Kevin D. Hermanson, Brian Dobkowski
Journal: Journal of the American Academy of Dermatology (2024)
53462 A worldwide survey shows that hormonal cycle irregularities, perimenopause and post-partum may influence the self-perception of skin disorders and impact the women’s wellbeing
Authors: Beatriz Sant’Anna, Claire Deloche, Stephanie Leclerc Mercier, Charles Taieb, Philippe Martel, Christos C. Zouboulis
Journal: Journal of the American Academy of Dermatology (2024)
53857 Urticaria Voices: Patients' and Physicians' Perceptions on Glucocorticoid Use in Chronic Spontaneous Urticaria
Authors: Jonathan Bernstein, Maria-Magdalena Balp, Jessica McCarthy, Merin Kuruvilla, Tara Raftery, Pallavi Saraswat, Tonya A. Winders, Karsten Weller
Journal: Journal of the American Academy of Dermatology (2024)
48854 Treatment with encapsulated benzoyl peroxide leads to a durable shift in the microbiome in rosacea
Authors: Raja K. Sivamani, Yvonne Nong, Jeffrey Sugarman, Jean Philippe York, Ofra Levy-Hacham, Dawnica Nadora, Aidan Galati, Richard L. Gallo
Journal: Journal of the American Academy of Dermatology (2024)
52624 Runners Associated Nail and Foot Abnormalities: A Questionnaire-Based and Photographic Assessment Study
Authors: Thrit Hutachoke, Sumanas Bunyaratavej, Charussri Leeyaphan, Phuwakorn Saengthong-aram, Supisara Wongdama, Pantaree Kobkurkul, Punyawee Ongsri
Journal: Journal of the American Academy of Dermatology (2024)
54723 Large Language Models as a Tool to Reduce Reading Grade-level of Online Health Information on Generalized Pustular Psoriasis
Authors: Samer Wahood, Benjamin Gallo Marin, Omar Alani, Afua Ofori-Darko, Darya Mirebrahimi, Waseem Wahood, Kathleen M. Mulligan, Sarem Rashid, Katie A. O’Connell, Arash Mostaghimi, Vinod E. Nambudiri
Journal: Journal of the American Academy of Dermatology (2024)
50536 A Tranexamic Acid, Niacinamide, and Acetyl Glucosamine Facial Serum Clinically Improved PIH and Post-Acne Marks in a Diverse Population
Authors: Zoe Diana Draelos, Brenda Edison, Sonia Trehan, Wen-Hwa Li, Surabhi Singh, Li Feng, Nikoleta Batchvarova, Ramine Parsa, Ritamarie Guerrero
Journal: Journal of the American Academy of Dermatology (2024)
54147 Efficacy of Ruxolitinib Cream for Treatment of Atopic Dermatitis in Children Aged 2–&lt;12 Years by Baseline Clinical Characteristics: Subgroup Analysis From a Randomized Phase 3 Study (TRuE-AD3)
Authors: April W. Armstrong, Lawrence F. Eichenfield, Lara Wine Lee, Kanwaljit K. Brar, Joel C. Joyce, Seth B. Forman, Weily Soong, Howard Sofen, Brett Angel, Qian Li, Linda F. Stein Gold
Journal: Journal of the American Academy of Dermatology (2024)
51443 Sub-micron emulsion based mild bodywash formulations for superior active deposition
Authors: Teanoosh Moaddel, Guilherme Bertola, Congling Quan, Bivash Dasgupta, Naresh Ghatlia, Anat Shiloach, Anson Ma, Yushuo Niu, Paul Vinski, Qian Yang
Journal: Journal of the American Academy of Dermatology (2024)
52871 Tapinarof Cream 1% Once Daily is Efficacious for the Treatment of Moderate to Severe Atopic Dermatitis in Patients with Skin of Color Down to 2 Years of Age in Two Pivotal Phase 3 Trials
Authors: Andrew F. Alexis, Leon Kircik, Raj Chovatiya, Zakiya P. Rice, Tina Bhutani, Philip M. Brown, Stephen C. Piscitelli, David S. Rubenstein, Anna M. Tallman, April W. Armstrong
Journal: Journal of the American Academy of Dermatology (2024)
50623 The Effects of Geographic Location, Demographics, and Insurance Type on Access to Pediatric-Dermatologic Care
Authors: Stephanie Munie, Sophia Daniel, Courtney Linkous, Ansley DeVore, Chelsea Shope, Laura Andrews, Kelly Atherton, Caroline Brailsford, Ashley Girvin, Lara Wine Lee, Colleen Cotton
Journal: Journal of the American Academy of Dermatology (2024)
51441 Real-World Switch Rates in Patients with Psoriasis Treated with Biologics Over 3 Years in the United States
Authors: April W. Armstrong, Manish Patel, Chao Li, Vishvas Garg, Jashin J. Wu
Journal: Journal of the American Academy of Dermatology (2024)

Introduction: Among patients with psoriasis (PsO), switching therapies is common due to poor treatment outcomes, including lack of efficacy or safety/tolerability issues. This study compared real-world switch rates among patients with PsO treated with biologics over a 36-month period.
53463 Are positive antithyroid antibodies more frequent in extensive vitiligo patients?
Authors: David Castillo-Molina, Sara Muñoz-Ordoñez, Laura D. Rojas-Torres, Jesús D. Fierro-Lozada, Yensi Lorena Romero-Días, Daniela I. Palomino-García, David E. Castillo-Saavedra, Meagan Ashley Norberta Klyn
Journal: Journal of the American Academy of Dermatology (2024)
54211 A Novel Topical Exfoliative Serum containing Taurine, Phytic Acid, Mandelic Acid, Salicylic Acid, and Lactic Acid Integrated with a Chemical Peel Improves Photodamage and Signs of Facial Aging
Authors: Edward Lain, Hina Choudhary, Patricia Brieva, Stacy White
Journal: Journal of the American Academy of Dermatology (2024)
53978 Effectiveness and Safety of a Resilient Hyaluronic Acid Filler Versus Restylane-L® For Lip Augmentation
Authors: Ava Shamban, Sabrina Fabi, Steven H. Dayan, John Joseph, Joely Kaufman-Janette, Zoe Draelos, Susan Winkle
Journal: Journal of the American Academy of Dermatology (2024)
54148 Characteristics of Real-world Patients With Psoriasis Prescribed Guselkumab or Interleukin-17 Inhibitors: Data From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Authors: Bruce Strober, Matthias Augustin, Yayoi Tada, Kimberly Parnell Lafferty, Elizabeth Skobelev, Wayne Langholff, Steven Fakharzadeh, Robert Gniadecki
Journal: Journal of the American Academy of Dermatology (2024)
53779 Fixed-Combination Halobetasol Propionate 0.01%/Tazarotene 0.045% and Halobetasol Propionate 0.01% Lotions for Plaque Psoriasis on Lower Extremities With Body Hair
Authors: Linda Stein Gold, Edward Lain, George Han, Abby Jacobson
Journal: Journal of the American Academy of Dermatology (2024)
53894 Roflumilast foam 0.3% once daily in patients with seborrheic dermatitis: Improvement in patient reported outcomes and pruritus from a phase 3 trial (STRATUM)
Authors: Neal Bhatia, Fran Cook-Bolden, Janet DuBois, Laura Ferris, Linda Stein Gold, Irina Turchin, Matthew Zirwas, David Krupa, Patrick Burnett, David R. Berk, David H. Chu
Journal: Journal of the American Academy of Dermatology (2024)
52625 Optimal Duration for Specimen Transportation Using Specimen Storing Envelopes in Superficial Fungal Infections
Authors: Thrit Hutachoke, Sumanas Bunyaratavej, Lalita Matthapan, Chatisa Panyawong, Waranyoo Prasong, Akkarapong Plengpanich, Phuwakorn Saengthong-aram, Suthasanee Prasertsook, Bawonpak Pongkittilar, Pantaree Kobkurkul, Charussri Leeyaphan
Journal: Journal of the American Academy of Dermatology (2024)
54711 Nonconscious Proprioception Irregularities Observed in Chronic Venous Insufficiency (CVI) Patients with Healed Ulceration: An Age and Gender Matched Cross-Sectional Quantitative Comparative Study
Authors: Umayr Shaikh, Holly Shan, Wynne Zheng, Lydia Hu, Luke Llaurado, Claudia Fernandez Perez, Jie Jung Shih, Edward Hochman
Journal: Journal of the American Academy of Dermatology (2024)
51876 Impact of Long-Term Abrocitinib Treatment on Patient-Reported Outcomes and Quality of Life for Approximately 2 Years in Patients With Moderate-to-Severe Atopic Dermatitis: An Interim Analysis of JADE EXTEND, a Long-Term Extension Study
Authors: Melinda J. Gooderham, Eric L. Simpson, Sonja Ständer, Evangelia Papadavid, Paula C. Luna, Daniela E. Myers, Pinaki Biswas, Saleem A. Farooqui, Melissa Watkins
Journal: Journal of the American Academy of Dermatology (2024)
52652 Efficacy and safety of upadacitinib in prurigo nodularis
Authors: Youngbeom Kim, Jungsoo Lee, Jun-Oh Shin, Dongyoung Roh, Yeona Kim, Sang-Hyeon Won, Kihyuk Shin, Hoonsoo Kim, Hyunchang Ko, Moon-Bum Kim, Byungsoo Kim
Journal: Journal of the American Academy of Dermatology (2024)
53962 Efficacy of Povorcitinib for the Treatment of Vitiligo by Patient Demographics and Baseline Clinical Characteristics: Week 52 Subgroup Analysis From a Randomized, Placebo-Controlled, Phase 2b Clinical Trial
Authors: Amit G. Pandya, Thierry Passeron, Andrew Blauvelt, Nanja van Geel, Kurt Brown, Lois Erskine, Zhenyi Xue, Khaled Ezzedine
Journal: Journal of the American Academy of Dermatology (2024)
50233 Rocatinlimab Significantly Improves Clinical Responses in Patients with Moderate-To-Severe Atopic Dermatitis by Week 2 in a Randomized Double-Blind Placebo-Controlled Phase 2b Study
Authors: Emma Guttman-Yassky, Ehsanollah Esfandiari, Hirotaka Mano, Takahiro Arai, Kenji Kabashima
Journal: Journal of the American Academy of Dermatology (2024)
53817 Patient-reported outcomes with roflumilast foam 0.3% in patients with scalp and body psoriasis in the phase 3 ARRECTOR trial
Authors: Melinda Gooderham, Jerry Bagel, Seth B. Forman, Leon Kircik, Marni Wiseman, Benjamin Lockshin, Jennifer Soung, David Krupa, Saori Kato, David R. Berk, David H. Chu
Journal: Journal of the American Academy of Dermatology (2024)
53169 Neutrophil elastase levels do not differ between atopic dermatitis and psoriasis despite differences in Staphylococcus aureus burden.
Authors: Ania Stolarczyk, Eleanor Pope St. John, Fatima Bawany, Calla Fahey, Francisco Tausk, Patrick Schlievert, Lisa Beck, Takeshi Yoshida
Journal: Journal of the American Academy of Dermatology (2024)
49723 Improving Temple Hollowing With a Hyaluronic Acid Injectable Gel, VYC-20L: Results From a Multicenter, Randomized, Evaluator-Blinded, Controlled Pivotal Study
Authors: Deirdre Hooper, Leslie Baumann, Kenneth Beer, Brian Biesman, Derek Jones, José Raúl Montes, Smita Chawla, Kelly Leung
Journal: Journal of the American Academy of Dermatology (2024)
52888 Tolerance and efficacy of a serum containing Angiopausin and Thermal Spring water in adults with rosacea
Authors: Charlayne Yehouessi, Virginie RIBET, Thérèse NOCERA, Mélanie CHAPPUY, Gautier DOAT, Aline STENNEVIN, Marie Dominique THOUVENIN, Jean-Hilaire SAURAT
Journal: Journal of the American Academy of Dermatology (2024)
53140 Impact of Propranolol Initiation on Pediatric Patient Vital Signs with Infantile Hemangiomas
Authors: Katelyn Rypka, Gretchen Bellefeuille, Zachary Wendland, Briana Paiewonsky, Sheilagh Maguiness, Cynthia Nicholson
Journal: Journal of the American Academy of Dermatology (2024)
53695 Systemic exposure and safety profile of delgocitinib cream in adults with moderate to severe chronic hand eczema in the Phase 3 DELTA-2 trial
Authors: Melinda Gooderham, Diamant Thaçi, Tina Damgaard, Daniel Madsen, Anders Soehoel, Robert Bissonnette
Journal: Journal of the American Academy of Dermatology (2024)

In the DELTA-2 (NCT04872101) Phase 3 trial, delgocitinib cream 20 mg/g, a topical pan-Janus kinase inhibitor, was well-tolerated and demonstrated significant improvement in all efficacy endpoints versus cream vehicle in adults with moderate to severe chronic hand eczema (CHE). Pharmacokinetic blood sampling in DELTA-2 was performed 2-6 hours after delgocitinib application at Weeks 1, 4, and 16 using a liquid chromatography/mass spectrometry-based method (lower limit of quantitation: 5 pg/ml). In the Phase 1 trial (NCT05050279), single oral doses of delgocitinib were tested in healthy volunteers with sampling performed for up to 24-hours post-administration. In DELTA-2, minimal systemic exposure was recorded in 313 delgocitinib-treated patients, with the highest geometric mean plasma concentration being 0.21 ng/ml at Week 1 (n=286). In the Phase 1 trial, the lowest oral delgocitinib dose tested (1.5 mg; n=8) is regarded as subtherapeutic and showed a peak systemic exposure (geometric mean Cmax) of 7.2 ng/ml. In DELTA-2, adverse events (AEs) were reported by 45.7% (n=143/313; delgocitinib cream) and 44.7% (n=71/159; cream vehicle) of patients, with COVID-19 being most common (11.5% vs 12.6%, respectively). The rate of possibly or probably related AEs was low and similar between delgocitinib cream and cream vehicle. No deaths were reported. Few serious AEs were reported with none assessed as related to the study drug. The DELTA-2 trial demonstrated minimal systemic exposure in association with a favorable safety profile, supporting a lack of meaningful systemic effect from twice-daily applications of delgocitinib cream in patients with moderate to severe CHE.
53272 Vitiligo Vulgaris as a Significant Cutaneous Comorbidity in Myasthenia Gravis
Authors: Kazim Jaffry, James Lin, Suhayb Islam, Narjis Jaffry, Justin Matos, Reza Mohammed Ali, Michelle Karpenos, Sohaib Hassan, Kranthi Mandava, Nizar Souayah
Journal: Journal of the American Academy of Dermatology (2024)
53420 Temporal Trends in Sun Protective Behaviors in Hispanic and Non-Hispanic White Individuals in the United States
Authors: Lauren M. Fahmy, Celine M. Schreidah, Caroline Chen, Oluwaseyi Adeuyan, Emily R. Gordon, Brigit A. Lapolla, Larisa J. Geskin
Journal: Journal of the American Academy of Dermatology (2024)

Recent data suggests that sun-protective behaviors have become more prevalent over the past decade(1). However, it remains unknown whether these changes have occurred variably across racial and ethnic groups. The objective of this study was to assess temporal trends in the prevalence of sun-protective behaviors in Non-Hispanic White (NHW) and Hispanic individuals in the United States. Using nationally representative data from the 2005 and 2020 National Health Interview Surveys(2), we calculated the weighted prevalence of sun-protective behaviors and performed a multivariable logistic regression to assess the association between year and sun-protective behaviors, adjusting for age, sex, region, and skin sensitivity to the sun. From 2005 to 2020, the prevalence of sun avoidance, sunscreen use, and sun-protective clothing use increased among both NHW and Hispanic participants while the prevalence of sunburn decreased in both groups. Although the absolute prevalence of sunscreen use was lower among Hispanic participants, they exhibited higher odds of sunscreen use in 2020 versus 2005 as compared to NHW participants. Hispanic participants also exhibited higher odds of sun-protective clothing use and lower odds of sunburn in 2020 versus 2005 compared to their NHW counterparts. Our findings suggest increases in sun-protective behaviors among both NHW and Hispanic individuals in 2020 compared to 2005. Moreover, they indicate that Hispanic individuals may be adopting these behaviors at faster rates than NHW individuals. Interestingly, this trend coincides with a worsening disparity in melanoma-specific survival among Hispanic individuals in recent years(3). Addressing this disparity may therefore require prioritizing factors beyond primary prevention strategies.
53555 Endocrine disorders in patients with inflammatory dermatosis
Authors: David Castillo-Molina, Jesus Daniel Fierro-Lozada, Daniela María Gutierrez-Murcia, Laura-Daniela Rojas-Torres, Cindy Lorena Abril-Ardila, Karen Sofia Corredor-López, Jennipher Andrea Blanco-Gómez, Meagan Ashley Norberta Klyn, David E. Castillo-Saavedra
Journal: Journal of the American Academy of Dermatology (2024)
50189 The Impact of Body Mass Index on Treatment Response to Secukinumab for Patients With Hidradenitis Suppurativa: A Post-Hoc Analysis of the SUNSHINE and SUNRISE Trials
Authors: Amit Garg, Farida Benhadou, Angel S. Byrd, Vincenzo Bettoli, Ryan Sullivan, Ivette Alcaron, Iryna Lobach, Christine-Elke Ortmann, Magdalena Wozniak, Raja Sivamani
Journal: Journal of the American Academy of Dermatology (2024)
50301 The Impact of Sex on Treatment Response to Secukinumab for Patients With Hidradenitis Suppurativa: A Post-Hoc Analysis of the SUNSHINE and SUNRISE Trials
Authors: Christopher Sayed, Ziad Reguiai, Jennifer L. Hsiao, Stephanie Mehlis, Eva Vilarrasa, John Darcy, Nicolas Thomas, Iryna Lobach, Christine-Elke Ortmann, Angela Llobet Martinez, Vivian Y. Shi
Journal: Journal of the American Academy of Dermatology (2024)
53303 Repurposing the Composite Assessment of Index Lesion Severity Scoring System in Cutaneous Lichen Planus
Authors: Nan Zhang, Angelina Hwang, Jacob Kechter, Shams Nassir, Fangyi Xie, Samantha Zunich, Emily Branch, Amylou Dueck, Julia Lehman, Mark Pittelkow, Aaron Mangold
Journal: Journal of the American Academy of Dermatology (2024)
52671 Bimekizumab safety and tolerability in moderate to severe plaque psoriasis: Pooled analysis from up to 4 years of treatment in 5 phase 3/3b clinical trials
Authors: Kenneth B. Gordon, Diamant Thaçi, Melinda Gooderham, Yukari Okubo, Bruce Strober, Luke Peterson, Delphine Deherder, José M. López Pinto, Paolo Gisondi
Journal: Journal of the American Academy of Dermatology (2024)
52758 Patient and clinician-reported outcomes with tirbanibulin 1% treatment for actinic keratosis in routine clinical practice across the U.S. according to treated area location (PROAK study)
Authors: Todd Schlesinger, Leon Kircik, James Del Rosso, Brian Berman, April Armstrong, Neal Bhatia, Mark Lebwohl, Vishal A. Patel, Darrell Rigel, Siva Narayanan, Ismail Kasujee
Journal: Journal of the American Academy of Dermatology (2024)
51221 Treatment pattern, unmet medical needs and treatment preference of systemic treatments for moderate-to-severe psoriasis from the perspectives of patients and dermatologists in China: A cross-sectional survey study
Authors: Yehong Kuang, Yuzhen Li, Chengzhi Lv, Min Li, Zhenying Zhang, Wendong Chen, Xingzhi Wang, Lina Ba, Yichen Zhong, Steven Feldman, Xiang Chen
Journal: Journal of the American Academy of Dermatology (2024)
51843 Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa: results from the 700 first patients of the Copenhagen Hidradenitis Suppurativa Cohort Study
Authors: Nikolaj Holgersen, None NH, Valdemar Wendelboe Nielsen, Nana Aviaaja Lippert Roseno, Jacob P. Thyssen, Alexander Egeberg, Signe Holm Nielsen, Hans Christian Ring, Simon Francis Thomsen
Journal: Journal of the American Academy of Dermatology (2024)
52244 Early Improvement in Nail and Scalp Psoriasis from a Prospective Observational Study of Patients with Psoriasis in Special Areas (PSoSA) Initiating Ixekizumab: Results from the First Interim Analysis
Authors: Jerry Bagel, Kenneth Dawes, Jessica Burgy, Edward Herman, Meghan Feely, Aisha Vadhariya, William N. Malatestinic, Kyoungah See, Baojin Zhu, Joseph F. Merola
Journal: Journal of the American Academy of Dermatology (2024)
52237 Multi-omics and integrative approach to understand microcomedone ecosystem and evaluate the pharmaco-clinical efficacy of an acne prone skin product containing Silybum Marianum Fruit Extract
Authors: Celine MIAS, Therese Nocera, Camille Genies, Alexia Brocario, Gwendal Josse, Gautier Doat, Sandrine Bessou-Touya, Pascal Reygagne, Jean-Hilaire Saurat, Helene Duplan
Journal: Journal of the American Academy of Dermatology (2024)
53713 Dupilumab Treatment Provides Long-Term Disease Control in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis Over 1 Year
Authors: Elaine Siegfried, Eric Simpson, Mark Boguniewicz, Carsten Flohr, Lawrence Eichenfield, Andreas Pinter, Michele Ramien, Xing-Hua Gao, Zhen Chen, Lauren Bates, Ana Rossi
Journal: Journal of the American Academy of Dermatology (2024)
53949 Tapinarof Cream 1% Once Daily was Well Tolerated for the Treatment of Adults and Children Down to 2 Years of Age with Moderate to Severe Atopic Dermatitis Across Two Pivotal Phase 3 Trials
Authors: Linda Stein Gold, James Del Rosso, Benjamin D. Ehst, Matthew J. Zirwas, Lawrence J. Green, Philip M. Brown, Anna M. Tallman, David S. Rubenstein, Stephen C. Piscitelli
Journal: Journal of the American Academy of Dermatology (2024)
52381 Treatment of hidradenitis suppurativa fistulas with intralesional cryotherapy guided by cutaneous ultrasound: a prospective descriptive study
Authors: Francisco José Rodríguez-Cuadrado, Juan Luis Castaño-Fernández, Victoria Ortiz-Berciano, Gaston Roustan-Gullón, Fernando Alfageme-Roldán
Journal: Journal of the American Academy of Dermatology (2024)
52756 Bimekizumab impact on draining tunnels in patients with moderate to severe hidradenitis suppurativa: Pooled 48-week data from BE HEARD I &amp; II
Authors: Christos C. Zouboulis, Staedtisches Klinikum Dessau, Jennifer Hsiao, Ziad Reguiai, Pierre-André Becherel, Brian Kirby, John W. Frew, Luke Peterson, Ingrid Pansar, Muhammed Bari, Christopher Sayed
Journal: Journal of the American Academy of Dermatology (2024)
49690 Long-term efficacy of baricitinib in alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2
Authors: Maryanne Senna, Arash Mostaghimi, Manabu Ohyama, Rodney Sinclair, Chiara Chiasserini, Yves Dutronc, Najwa Somani, Guanglei Yu, Jill Kolodsick, Brett King
Journal: Journal of the American Academy of Dermatology (2024)
49513 Effectiveness and Persistence of Brodalumab in Patients with Plaque Psoriasis in the Canadian Real-World Setting: 3-Month Follow-up Results from the CARE Study
Authors: Véronique Gaudet, Marni Wiseman, Sunil Kalia, Raj Tuppal, Vimal H. Prajapati, Angélique Gagné-Henley, Tracey Brown-Maher, Martin Barbeau, Maxime Barakat, Calum Neish
Journal: Journal of the American Academy of Dermatology (2024)
52736 Assessment of Color Match of Universal Tinted Sunscreens in Fitzpatrick Skin Phototypes I-VI
Authors: Mohsen Mokhtari, Redina Bardhi, Mavra Masood, Deena Abdel-Gadir, Dorothea McGowan, Brittany Lane, Marissa Ceresnie, Henry Lim, Iltefat Hamzavi, Indermeet Kohli, Tasneem Mohammad
Journal: Journal of the American Academy of Dermatology (2024)
54117 Disease journey and treatment outcomes: The real-world experience of patients with CSU
Authors: Jonathan Bernstein, Tonya A. Winders, Ivan Nikolaev, Maria-Magdalena Balp, Tara Raftery, Pallavi Saraswat, Jessica McCarthy, Merin Kuruvilla, Karsten Weller
Journal: Journal of the American Academy of Dermatology (2024)
49827 Estimated 24-hour urinary sodium excretion associated with severity of atopic dermatitis in the UK Biobank
Authors: Brenda Chiang, Morgan Ye, Aheli Chattopadhyay, Yagmur Halezeroglu, Erin Van Blarigan, Katrina Abuabara
Journal: Journal of the American Academy of Dermatology (2024)
50749 Analysis Of Sun-Safety Awareness And Sunscreen Use Patterns Amongst First And Second Generation American Immigrants Of African Descent
Authors: Afua Ofori-Darko, Bryan Carroll
Journal: Journal of the American Academy of Dermatology (2024)

Background: Skin of color (SOC) individuals are often perceived to have lower susceptibility to skin cancer and may consequently perceive less urgency in adopting sun protection measures such as sunscreen use1. However, SOC can, in fact, develop skin cancer and may experience poorer survival rates due to late detection2. While research has shown worse skin cancer outcomes in SOC, little is known about individuals of African descent in particular. This research aims to assess sunscreen use and sun-protective behaviors of first and second-generation African immigrants (FSGAI).